Show simple item record

Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy

dc.contributor.authorBenjamin Gesundheit*
dc.contributor.authorJoshua P. Rosenzweig*
dc.date.accessioned2021-02-11T21:38:40Z
dc.date.available2021-02-11T21:38:40Z
dc.date.issued2017*
dc.date.submitted2018-02-27 16:16:45*
dc.identifier25658*
dc.identifier.issn16648714*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/55224
dc.description.abstractThe ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune system will undoubtedly help guide the development of new strategies. Theranostic biomarkers to monitor these therapies in clinical trials serve an important need in this innovative field and demand further research.*
dc.languageEnglish*
dc.relation.ispartofseriesFrontiers Research Topics*
dc.subjectR5-920*
dc.subjectRC581-607*
dc.subjectRC254-282*
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.othertheranostic nanomedicine*
dc.subject.othercancer immunotherapy*
dc.subject.otheroncolytic viruses*
dc.subject.otherantitumor immunity*
dc.subject.otheroncoimmunology*
dc.subject.othergene expression*
dc.subject.othertransgenes*
dc.titleOncolytic Viruses - Genetically Engineering the Future of Cancer Therapy*
dc.typebook
oapen.identifier.doi10.3389/978-2-88945-358-0*
oapen.relation.isPublishedBybf5ce210-e72e-4860-ba9b-c305640ff3ae*
oapen.relation.isbn9782889453580*
oapen.pages193*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/